Is CDK9 a promising target for both primary and metastatic osteosarcoma?

por Qin, Jiang-Jiang
Publicado 2019

Drug-resistant HER2-positive breast cancer: Molecular mechanisms and overcoming strategies

por Wu, Xiaofan, Yang, Hongjian, Yu, Xingfei, Qin, Jiang-Jiang
Publicado 2022

STAT3 as a potential therapeutic target in triple negative breast cancer: a systematic review

por Qin, Jiang-Jiang, Yan, Li, Zhang, Jia, Zhang, Wei-Dong
Publicado 2019

Targeting the NFAT1-MDM2-MDMX Network Inhibits the Proliferation and Invasion of Prostate Cancer Cells, Independent of p53 and Androgen

por Qin, Jiang-Jiang, Li, Xin, Wang, Wei, Zi, Xiaolin, Zhang, Ruiwen
Publicado 2017

Dual roles and therapeutic potential of Keap1-Nrf2 pathway in pancreatic cancer: a systematic review

por Qin, Jiang-Jiang, Cheng, Xiang-Dong, Zhang, Jia, Zhang, Wei-Dong
Publicado 2019

Editorial: Biology and Pharmacological Effects of Extracellular Vesicles in Cancer

por Zhang, Jian-ye, Qin, Jiang-Jiang, Zhang, Dongmei, Yang, Dong-Hua
Publicado 2022

7H-Chromeno[3,2-h]quinolin-7-one methanol monosolvate

por Qin, Jiang-Ke, Yang, Zheng-Min, Zeng, Ming-Hua, Ng, Seik Weng
Publicado 2009

Tris[2-eth­oxy-6-(methyl­imino­meth­yl)phenolato-κ(2) N,O (1)]cobalt(III) monohydrate

por Huang, Yin Dan, Zhang, Shu-Hua, Qin, Jiang Ke, Chen, Fu Li
Publicado 2010

2,4-Di­bromo-1,3-dihy­droxy-9H-xanthen-9-one

por Huang, Shi-Wen, Yang, Zheng-Min, Huang, Fu-Ping, Qin, Jiang-Ke
Publicado 2013

Hexaaqua­cobalt(II) 5,5′-(propane-1,3-diyldithio)bis­(1H-tetra­zole-1-acetate)

por Liang, Wan-Ling, Yu, Qing, Zhang, Xiu-Qing, Qin, Jiang-Ke, Liang, Hong
Publicado 2009

Identification of lineariifolianoid A as a novel dual NFAT1 and MDM2 inhibitor for human cancer therapy

por Qin, Jiang-Jiang, Sarkar, Sushanta, Voruganti, Sukesh, Agarwal, Rajesh, Wang, Wei, Zhang, Ruiwen
Publicado 2016

Inulanolide A as a new dual inhibitor of NFAT1-MDM2 pathway for breast cancer therapy

por Qin, Jiang-Jiang, Wang, Wei, Sarkar, Sushanta, Voruganti, Sukesh, Agarwal, Rajesh, Zhang, Ruiwen
Publicado 2016

Natural products targeting the p53-MDM2 pathway and mutant p53: Recent advances and implications in cancer medicine

por Qin, Jiang-Jiang, Li, Xin, Hunt, Courtney, Wang, Wei, Wang, Hui, Zhang, Ruiwen
Publicado 2018

Combination value of diffusion-weighted imaging and dynamic susceptibility contrast-enhanced MRI in astrocytoma grading and correlation with GFAP, Topoisomerase IIα and MGMT

por Qin, Jiang-Bo, Zhang, Hui, Wang, Xiao-Chun, Tan, Yan, Wu, Xiao-Feng
Publicado 2019

Identification of an Immune Gene-Associated Prognostic Signature and Its Association With a Poor Prognosis in Gastric Cancer Patients

por Guan, Xiaoqing, Xu, Zhi-Yuan, Chen, Runzhe, Qin, Jiang-Jiang, Cheng, Xiang-Dong
Publicado 2021

In Silico Screening and Validation of PDGFRA Inhibitors Enhancing Radioiodine Sensitivity in Thyroid Cancer

por Yu, Xuefei, Zhu, Xuhang, Zhang, Lizhuo, Qin, Jiang-Jiang, Feng, Chunlai, Li, Qinglin
Publicado 2022

Identification of a new class of natural product MDM2 inhibitor: In vitro and in vivo anti-breast cancer activities and target validation

por Qin, Jiang-Jiang, Wang, Wei, Voruganti, Sukesh, Wang, Hui, Zhang, Wei-Dong, Zhang, Ruiwen
Publicado 2014

Inhibiting NFAT1 for breast cancer therapy: New insights into the mechanism of action of MDM2 inhibitor JapA

por Qin, Jiang-Jiang, Wang, Wei, Voruganti, Sukesh, Wang, Hui, Zhang, Wei-Dong, Zhang, Ruiwen
Publicado 2015

Inhibiting β-Catenin by β-Carboline-Type MDM2 Inhibitor for Pancreatic Cancer Therapy

por Qin, Jiang-Jiang, Wang, Wei, Li, Xin, Deokar, Hemantkumar, Buolamwini, John K., Zhang, Ruiwen
Publicado 2018

Lung Metastasis of Thyroid Cancer Appearing Diffuse and Disseminated on Imaging

por Xiang, Meng-Meng, Qin, Jiang-Yue, Shen, Yong-Chun, Jiang, Yong, Wen, Fu-Qiang
Publicado 2018